6856:TSEHoriba , Ltd. Analysis

HORIBA, Ltd. is trading at ¥18,830, comfortably above its 50‑day SMA (¥18,575) and 200‑day SMA (¥13,875) but below the 20‑day SMA (¥19,585), indicating a medium‑term bullish bias with short‑term pressure. The RSI sits at 46.5, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, warning of potential near‑term downside. The stock’s PE of 21.4 is well below the industry average of 33.7, and the DCF‑derived fair value of ¥10,062 implies a modest 1.8% upside, positioning the equity as fairly valued with a slight undervaluation. A dividend yield of 1.59% and a payout ratio of 33% are supported by a robust cash pile of ¥164.6 bn against ¥66.5 bn of debt, making the dividend sustainable. Volatility over the past 30 days is high at 44%, but beta is modest (≈0.8), tempering market‑wide risk exposure. Recent news of a dividend hike and special payout underscores management’s confidence in cash strength and shareholder returns. Revenue growth is modest at 1.3% YoY, yet operating margins remain healthy at 19%, and ROE stands at 11%, reflecting solid profitability. The company’s diversified exposure across energy, healthcare, and semiconductor instrumentation mitigates sector concentration risk. With stable trading volumes and a market cap near ¥791 bn, liquidity is ample. Overall, the blend of decent valuation, sustainable dividend, and resilient fundamentals supports a cautiously optimistic outlook.